AstraZeneca PLC (AZN) — QMA analysis
Sector: Healthcare · Market cap: $294.6B · Price: $171.49 · Data as of 2026-10-23
AstraZeneca PLC has an above-average composite score of 64/100, higher score than 97% of 22,733 tracked stocks. The highest-scoring layer is Catalysts; the lowest is Insider activity.
What 12 data layers say about AZN
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 74/100 |
| Earnings quality (EQS) | 63/100 |
| Technical trend (TSS) | 52/100 |
| Relative strength (RS) | 50/100 |
| Momentum (USS) | 56/100 |
| Insider activity (IAS) | 20/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 45/100 |
| Institutional 13F (IFS) | 62/100 |
| Options flow (OFS) | 72/100 |
| News sentiment (NSS) | 59/100 |
| Analysts / transcripts (ATS) | 59/100 |
| Catalysts (XS) | 93/100 |
What does the QMA model currently show for AstraZeneca PLC?
The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.
For AZN the layers diverge — some score high (Catalysts), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
AZN insider & smart money activity
For AZN we track the institutional footprint through FINRA off-exchange trading data (WHS 45/100) and reported 13F positions, filed with up to a 45-day delay (IFS 62/100). Detailed insider data for this stock is still being collected.
AZN seasonality
The historically strong window for AZN was April 1–28 with a hit rate of 67% and an average move of 4.2% (21 years of history).
Historical data does not guarantee future results.
AZN dividend
AstraZeneca PLC: 1.87% · 👑
How AZN compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for AZN stock?
64/100 (B) — Data as of 2026-10-23.
Are insiders buying AZN stock?
—
Where can I see live AZN data?
Live AZN data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]